Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pharmacyclics, Inc.    PCYC   US7169331060

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Biotechnology
Logo
Logo Pharmacyclics, Inc.
Surperformance© rating of Pharmacyclics, Inc.
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER - - -
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision - - -
4 months Revenue revision
1 year Revenue revision - - -
More Ratings
Sector Biotechnology
CountryTrading RatingInvestor Rating
GILEAD SCIENCES, INC.USA
AMGEN, INC.USA
CELGENE CORPORATIONUSA
BIOGEN IDEC INC.USA
CSL LIMITEDAUSTRALIA
REGENERON PHARMACEUTICALS INCUSA
VERTEX PHARMACEUTICALS INCORPORATEDUSA
LIFE TECHNOLOGIES CORP.USA
ACTELION LTDSwitzerland
ONYX PHARMACEUTICALS, INC.USA
PHARMACYCLICS, INC.USA
QIAGEN NVUSA
COVANCE INC.USA
BEIJING SL PHARMACEUTICAL CO., LTD.CHINA
JAZZ PHARMACEUTICALS PLCUSA
LONZA GROUP AGSwitzerland
ALKERMES PLCUSA
SEATTLE GENETICS, INC.USA
MEDIVATION INCUSA
UNITED THERAPEUTICS CORPORATIONUSA
EUROFINS SCIENTIFICFrance
CELLTRION, INC.KOREA, REPUBLIC OF
INCYTE CORPORATIONUSA
PAREXEL INTERNATIONAL CORPORATIONUSA
ISIS PHARMACEUTICALS, INC.USA
Sector Biotechnology
Data source :
© 2013 Thomson Reuters		 Ratings :
© 2013 Surperformance
Advertisement
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.